Half-year report · HY

Period2025-04-01 → 2025-09-30
Filed2025-11-10
StandardJapan GAAP
ConsolidatedYes
Data checks14 of 14 passed
Key figures · 44
MetricValuePeriodScopeSource row
Revenue¥277.1bn2025-04-01 → 2025-09-30Cons.Net sales
Revenue¥586.5bn2024-04-01 → 2025-03-31Cons.Net sales (5-year summary)
Revenue¥289.7bn2024-04-01 → 2024-09-30Cons.Net sales
Operating income¥20.1bn2025-04-01 → 2025-09-30Cons.Operating income
Operating income¥31.6bn2024-04-01 → 2024-09-30Cons.Operating income
Ordinary income¥20.4bn2025-04-01 → 2025-09-30Cons.Ordinary income
Ordinary income¥62.3bn2024-04-01 → 2025-03-31Cons.Ordinary income loss (5-year summary)
Ordinary income¥30.7bn2024-04-01 → 2024-09-30Cons.Ordinary income
Profit before tax¥26.2bn2025-04-01 → 2025-09-30Cons.Income before income taxes
Profit before tax¥41.8bn2024-04-01 → 2024-09-30Cons.Income before income taxes
Net income (owners)¥18.8bn2025-04-01 → 2025-09-30Cons.Profit loss attributable to owners of parent
Net income (owners)¥49.5bn2024-04-01 → 2025-03-31Cons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥32.1bn2024-04-01 → 2024-09-30Cons.Profit loss attributable to owners of parent
Net income¥19.2bn2025-04-01 → 2025-09-30Cons.Profit loss
Net income¥32.6bn2024-04-01 → 2024-09-30Cons.Profit loss
Total assets¥848.9bnat 2025-09-30Cons.Assets
Total assets¥813.8bnat 2025-03-31Cons.Assets
Total assets¥827.8bnat 2024-09-30Cons.Total assets (5-year summary)
Total liabilities¥454.7bnat 2025-09-30Cons.Liabilities
Total liabilities¥438.8bnat 2025-03-31Cons.Liabilities
Net assets / equity¥394.2bnat 2025-09-30Cons.Net assets
Net assets / equity¥375.0bnat 2025-03-31Cons.Net assets
Net assets / equity¥392.3bnat 2024-09-30Cons.Net assets (5-year summary)
Cash and deposits¥64.7bnat 2025-09-30Cons.Cash and deposits
Cash and deposits¥65.1bnat 2025-03-31Cons.Cash and deposits
Cash & equivalents¥64.4bnat 2025-09-30Cons.Cash and cash equivalents
Cash & equivalents¥64.8bnat 2025-03-31Cons.Cash and cash equivalents
Cash & equivalents¥64.4bnat 2024-09-30Cons.Cash and cash equivalents
Cash & equivalents¥68.4bnat 2024-03-31vCons.Cash and cash equivalents
Operating cash flow¥32.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in operating activities
Operating cash flow¥93.4bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow¥50.7bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in operating activities
Investing cash flow−¥26.5bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in investment activities
Investing cash flow−¥47.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥29.4bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in investment activities
Financing cash flow−¥7.8bn2025-04-01 → 2025-09-30Cons.Net cash provided by used in financing activities
Financing cash flow−¥48.9bn2024-04-01 → 2025-03-31Cons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow−¥24.0bn2024-04-01 → 2024-09-30Cons.Net cash provided by used in financing activities
EPS (basic)¥70.92025-04-01 → 2025-09-30Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥181.442024-04-01 → 2025-03-31Cons.Basic earnings loss per share (5-year summary)
EPS (basic)¥116.182024-04-01 → 2024-09-30Cons.Basic earnings loss per share (5-year summary)
Equity ratio44.7%at 2025-09-30Cons.Equity to asset ratio (5-year summary)
Equity ratio44.2%at 2025-03-31Cons.Equity to asset ratio (5-year summary)
Equity ratio45.5%at 2024-09-30Cons.Equity to asset ratio (5-year summary)

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 65
SegmentItemPeriodValue
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2025-04-01 → 2025-09-30¥9.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2025-04-01 → 2025-09-30¥2.5bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2025-04-01 → 2025-09-30¥7.3bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2025-04-01 → 2025-09-30¥400m
Reconciling Itemsreconcilingrevenue2025-04-01 → 2025-09-30−¥13.4bn
Reconciling Itemsreconcilingrevenue intersegment2025-04-01 → 2025-09-30−¥13.4bn
Engineering Plasticsreportable segmentrevenue2025-04-01 → 2025-09-30¥122.0bn
Engineering Plasticsreportable segmentrevenue external2025-04-01 → 2025-09-30¥121.9bn
Engineering Plasticsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥106m
Engineering Plasticsreportable segmentsegment profit2025-04-01 → 2025-09-30¥11.5bn
Materialsreportable segmentrevenue2025-04-01 → 2025-09-30¥83.1bn
Materialsreportable segmentrevenue external2025-04-01 → 2025-09-30¥77.2bn
Materialsreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥5.9bn
Materialsreportable segmentsegment profit2025-04-01 → 2025-09-30¥5.0bn
Medical Healthcarereportable segmentrevenue2025-04-01 → 2025-09-30¥7.6bn
Medical Healthcarereportable segmentrevenue external2025-04-01 → 2025-09-30¥7.6bn
Medical Healthcarereportable segmentsegment profit2025-04-01 → 2025-09-30¥208m
Safetyreportable segmentrevenue2025-04-01 → 2025-09-30¥49.7bn
Safetyreportable segmentrevenue external2025-04-01 → 2025-09-30¥49.7bn
Safetyreportable segmentsegment profit2025-04-01 → 2025-09-30¥2.7bn
Smartreportable segmentrevenue2025-04-01 → 2025-09-30¥18.2bn
Smartreportable segmentrevenue external2025-04-01 → 2025-09-30¥18.2bn
Smartreportable segmentrevenue intersegment2025-04-01 → 2025-09-30¥67m
Smartreportable segmentsegment profit2025-04-01 → 2025-09-30¥404m
—segment totalrevenue2025-04-01 → 2025-09-30¥280.7bn
—segment totalrevenue external2025-04-01 → 2025-09-30¥274.6bn
—segment totalrevenue intersegment2025-04-01 → 2025-09-30¥6.1bn
—segment totalsegment profit2025-04-01 → 2025-09-30¥19.7bn
Total Of Reportable Segments And Otherssegment totalrevenue2025-04-01 → 2025-09-30¥290.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2025-04-01 → 2025-09-30¥277.1bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2025-04-01 → 2025-09-30¥13.4bn
Total Of Reportable Segments And Otherssegment totalsegment profit2025-04-01 → 2025-09-30¥20.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue2024-04-01 → 2024-09-30¥9.9bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue external2024-04-01 → 2024-09-30¥2.8bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentsrevenue intersegment2024-04-01 → 2024-09-30¥7.1bn
Operating Segments Not Included In Reportable Segments And Other Revenue Generating Business Activitiesother segmentssegment profit2024-04-01 → 2024-09-30¥344m
Reconciling Itemsreconcilingrevenue2024-04-01 → 2024-09-30−¥13.8bn
Reconciling Itemsreconcilingrevenue intersegment2024-04-01 → 2024-09-30−¥13.8bn
Engineering Plasticsreportable segmentrevenue2024-04-01 → 2024-09-30¥124.6bn
Engineering Plasticsreportable segmentrevenue external2024-04-01 → 2024-09-30¥124.5bn
Engineering Plasticsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥96m
Engineering Plasticsreportable segmentsegment profit2024-04-01 → 2024-09-30¥15.2bn
Materialsreportable segmentrevenue2024-04-01 → 2024-09-30¥95.1bn
Materialsreportable segmentrevenue external2024-04-01 → 2024-09-30¥88.5bn
Materialsreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥6.6bn
Materialsreportable segmentsegment profit2024-04-01 → 2024-09-30¥14.3bn
Medical Healthcarereportable segmentrevenue2024-04-01 → 2024-09-30¥7.2bn
Medical Healthcarereportable segmentrevenue external2024-04-01 → 2024-09-30¥7.2bn
Medical Healthcarereportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥0
Medical Healthcarereportable segmentsegment profit2024-04-01 → 2024-09-30¥189m
Safetyreportable segmentrevenue2024-04-01 → 2024-09-30¥47.1bn
Safetyreportable segmentrevenue external2024-04-01 → 2024-09-30¥47.1bn
Safetyreportable segmentsegment profit2024-04-01 → 2024-09-30¥1.3bn
Smartreportable segmentrevenue2024-04-01 → 2024-09-30¥19.6bn
Smartreportable segmentrevenue external2024-04-01 → 2024-09-30¥19.6bn
Smartreportable segmentrevenue intersegment2024-04-01 → 2024-09-30¥51m
Smartreportable segmentsegment profit2024-04-01 → 2024-09-30¥215m
—segment totalrevenue2024-04-01 → 2024-09-30¥293.6bn
—segment totalrevenue external2024-04-01 → 2024-09-30¥286.9bn
—segment totalrevenue intersegment2024-04-01 → 2024-09-30¥6.7bn
—segment totalsegment profit2024-04-01 → 2024-09-30¥31.3bn
Total Of Reportable Segments And Otherssegment totalrevenue2024-04-01 → 2024-09-30¥303.5bn
Total Of Reportable Segments And Otherssegment totalrevenue external2024-04-01 → 2024-09-30¥289.7bn
Total Of Reportable Segments And Otherssegment totalrevenue intersegment2024-04-01 → 2024-09-30¥13.8bn
Total Of Reportable Segments And Otherssegment totalsegment profit2024-04-01 → 2024-09-30¥31.6bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 588
ItemContextValueUnit
Equity in earnings losses of affiliates ope cfPrior1InterimDuration-1407000000JPY
Equity in earnings losses of affiliates ope cfInterimDuration-1414000000JPY
Loss gain on sales and retirement of noncurrent assets ope cfPrior1InterimDuration271000000JPY
Loss gain on sales and retirement of noncurrent assets ope cfInterimDuration824000000JPY
Loss gain on sales of investment securities ope cfPrior1InterimDuration-6756000000JPY
Loss gain on sales of investment securities ope cfInterimDuration-5077000000JPY
Loss gain on sales of stocks of subsidiaries and affiliates ope cfPrior1InterimDuration-4543000000JPY
Loss gain on sales of stocks of subsidiaries and affiliates ope cfInterimDuration-JPY
Decrease increase in notes and accounts receivable trade ope cfPrior1InterimDuration11318000000JPY
Decrease increase in notes and accounts receivable trade ope cfInterimDuration12866000000JPY
Decrease increase in inventories ope cfPrior1InterimDuration-5022000000JPY
Decrease increase in inventories ope cfInterimDuration-5736000000JPY
Increase decrease in notes and accounts payable trade ope cfPrior1InterimDuration3432000000JPY
Increase decrease in notes and accounts payable trade ope cfInterimDuration5574000000JPY
Gain on negative goodwill ope cfPrior1InterimDuration-JPY
Gain on negative goodwill ope cfInterimDuration-512000000JPY
Loss gain on step acquisitions ope cfPrior1InterimDuration-JPY
Loss gain on step acquisitions ope cfInterimDuration179000000JPY
Subsidy income ope cfPrior1InterimDuration-JPY
Subsidy income ope cfInterimDuration-1224000000JPY
Other net ope cfPrior1InterimDuration-895000000JPY
Other net ope cfInterimDuration-2538000000JPY
Subtotal ope cfPrior1InterimDuration58299000000JPY
Subtotal ope cfInterimDuration47280000000JPY
Interest and dividends income received ope cf inv cfPrior1InterimDuration1783000000JPY
Interest and dividends income received ope cf inv cfInterimDuration2263000000JPY
Interest expenses paid ope cf fin cfPrior1InterimDuration-685000000JPY
Interest expenses paid ope cf fin cfInterimDuration-1497000000JPY
Income taxes paid ope cfPrior1InterimDuration-8651000000JPY
Income taxes paid ope cfInterimDuration-15290000000JPY
Net cash provided by used in operating activitiesPrior1InterimDuration50745000000JPY
Net cash provided by used in operating activitiesInterimDuration32755000000JPY
Net decrease increase in time deposits inv cfPrior1InterimDuration4469000000JPY
Net decrease increase in time deposits inv cfInterimDuration101000000JPY
Purchase of property plant and equipment inv cfPrior1InterimDuration-43457000000JPY
Purchase of property plant and equipment inv cfInterimDuration-35429000000JPY
Proceeds from sales of property plant and equipment inv cfPrior1InterimDuration59000000JPY
Proceeds from sales of property plant and equipment inv cfInterimDuration5795000000JPY
Purchase of intangible assets inv cfPrior1InterimDuration-1254000000JPY
Purchase of intangible assets inv cfInterimDuration-1304000000JPY
Purchase of investment securities inv cfPrior1InterimDuration-147000000JPY
Purchase of investment securities inv cfInterimDuration-75000000JPY
Proceeds from sales and redemption of investment securities inv cfPrior1InterimDuration7844000000JPY
Proceeds from sales and redemption of investment securities inv cfInterimDuration5803000000JPY
Purchase of stocks of subsidiaries and affiliates inv cfPrior1InterimDuration-JPY
Purchase of stocks of subsidiaries and affiliates inv cfInterimDuration-714000000JPY
Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cfPrior1InterimDuration3527000000JPY
Proceeds from sales of investments in subsidiaries resulting in change in scope of consolidation inv cfInterimDuration-JPY
Other net inv cfPrior1InterimDuration-434000000JPY
Other net inv cfInterimDuration-707000000JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 14 of 14 passed
balance sheet identityconsolidated 2025-03-31pass
balance sheet identityconsolidated 2025-09-30pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2025-03-31pass
statement vs summary · net assetsconsolidated 2025-09-30pass
statement vs summary · net income attributable to parentconsolidated 2024-04-01/2024-09-30pass
statement vs summary · net income attributable to parentconsolidated 2025-04-01/2025-09-30pass
statement vs summary · operating cash flowconsolidated 2024-04-01/2024-09-30pass
statement vs summary · operating cash flowconsolidated 2025-04-01/2025-09-30pass
statement vs summary · revenueconsolidated 2024-04-01/2024-09-30pass
statement vs summary · revenueconsolidated 2025-04-01/2025-09-30pass
statement vs summary · total assetsconsolidated 2025-03-31pass
statement vs summary · total assetsconsolidated 2025-09-30pass